Olokizumab( —— )

Catalog No. M36700 CAS No. 1007223-17-7

Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6), primarily used in rheumatoid arthritis (RA) research .

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	385	Get Quote
5MG	620	Get Quote
10MG	845	Get Quote
25MG	1187	Get Quote
50MG	1628	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Olokizumab
Note

Research use only, not for human use.
Brief Description

Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6), primarily used in rheumatoid arthritis (RA) research .
Description

Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

1007223-17-7
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Kretsos K, et, al. Model-Based Optimal Design and Execution of the First-Inpatient Trial of the Anti-IL-6, Olokizumab. CPT Pharmacometrics Syst Pharmacol. 2014 Jun 18;3(6):e119.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks